FDA Device recall Z-0840-2016
CR Flex GSF Porous Femoral LPS Flex GSF Porous Femoral LPS Flex Porous Femoral prosthesis, knee, patello/femorotibial, semi-constrained, un…
- FDA Device
- Class II
- terminated
- Published 2016-03-02
On 2016-03-02 the FDA classified a Class II recall of CR Flex GSF Porous Femoral LPS Flex GSF Porous Femoral LPS Flex Porous Femoral prosthesis, knee, patello/femorotibial, semi-constrained, un… by Zimmer Biomet, citing LDPE bag containing the implant adheres to the highly polished implant surface.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-0840-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-01-11 |
| Published | 2016-03-02 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Zimmer Biomet |
| Distribution | US |
Product
CR Flex GSF Porous Femoral LPS Flex GSF Porous Femoral LPS Flex Porous Femoral prosthesis, knee, patello/femorotibial, semi-constrained, uncemented, porous, coated, polymer/metal/polymer various sizes This device is indicated for patients with severe knee pain and disability due to: Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis. Collagen disorders, and/or avascular necrosis of the femoral condyle. Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy. Moderate valgus, varus, or flexion deformities. The salvage of previously failed surgical attempts or for a knee in which satisfactory stability in flexion cannot be obtained at the time of surgery. " The CR-Flex GSF and LPS-Flex GSF uncoated (Option) and precoat styles are intended for cemented use only. " The CR-Flex GSF and LPS-Flex GSF porous coated femoral components may be used cemented or uncemented (biological fixation). " Specific uses with CR-Flex GSF or LPS-Flex GSF femorals: Provides increased flexion capability for patients who have both the flexibility and desire to increase their flexion range. The CR-Flex GSF femoral, when used with 90-prefix NexGen CR articular surfaces, 00-prefix 10, 12 or 14 mm or 90-prefix 17 or 20 mm Prolong¿ Highly Crosslinked Polyethylene CR articular surfaces, or with Gender Solutions Natural-Knee Flex Congruent articular surfaces, is designed for use with a functional posterior cruciate ligament and when load bearing range of motion (ROM) is expected to be less than or equal to 155 degrees. The LPS-Flex GSF femoral, when used with LPS-Flex articular surfaces, is designed for use with both cruciate ligaments excised and when load bearing ROM is expected to be less than or equal to 155 degrees."
Reason
LDPE bag containing the implant adheres to the highly polished implant surface.
Identifiers
| code_info | Item numbers: 00-5752-013-01 00-5752-013-02 00-5752-013-05 00-5752-013-06 00-5752-014-01 00-5752-014-02 00-5752-…Item numbers: 00-5752-013-01 00-5752-013-02 00-5752-013-05 00-5752-013-06 00-5752-014-01 00-5752-014-02 00-5752-014-05 00-5752-014-06 00-5752-015-01 00-5752-015-02 00-5752-015-05 00-5752-015-06 00-5752-016-01 00-5752-016-02 00-5752-016-05 00-5752-016-06 00-5752-017-01 00-5752-017-02 00-5752-017-05 00-5752-017-06 00-5762-013-51 00-5762-013-52 00-5762-014-51 00-5762-014-52 00-5762-015-51 00-5762-015-52 00-5762-016-51 00-5762-016-52 00-5762-017-51 00-5762-017-52 00-5962-012-51 00-5962-012-52 00-5962-013-51 00-5962-013-52 00-5962-014-51 00-5962-014-52 00-5962-015-51 00-5962-015-52 00-5962-016-51 00-5962-016-52 00-5962-017-51 00-5962-017-52 00-5962-018-51 00-5962-018-52 Lot numbers: 11003002 11003328 11003397 11003526 11003606 11003637 11003639 11003667 11003972 11004037 11004739 11004835 11004913 11004915 11005025 11005124 11005180 11005183 11005286 11005287 11005288 11005389 11005454 11005613 11005669 11005756 11005 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0840-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.